November 2018 FDA Recall Drug by Remedyrepack Inc.
D-0284-2019 - Cross contamination with other products

This Class III drug recall was voluntarily initiated by Remedyrepack Inc. on November 7, 2018 for the product Drug. The FDA reported the reason for recall as cross contamination with other products. The product was distributed in Product was distributed to two medical facilities in Pennsylvania. and the recall is currently terminated.

Recall Number: D-0284-2019

Reason for Recall
Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).
Initiated
11-07-2018
Reported
12-05-2018
Quantity
3,148 capsules

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Product was distributed to two medical facilities in Pennsylvania.
Nitrofurantoin Monohydrate/Macrocrystals capsules,100 mg, packaged in HDPE 60 cc bottles, Rx only, MFG: Sandoz Inc., Princeton, NJ, Repackaged by: RemedyRepack, Indiana, PA, Original NDC 00185-0122-01Repackaged NDC 70518-1087-00, 14 capsules in HDPE 60 cc bottles in cardboard trays & HDPE 60 cc bottles in plastic bags, Repackaged NDC 70518-1087-01, 10 capsules in HDPE 60 cc bottles in cardboard trays.

Batch or Lot Expiration Information

Lot# : B0484872-081718, B0481339-081018, Exp 08/2019; B0506246-092718, Exp 09/2019; B0509938-100418, Exp 10/2019